Transcription of 795 PHARMACEUTICAL COMPOUNDING—NONSTERILE ... - …
{{id}} {{{paragraph}}}
Example: biology
795 PHARMACEUTICAL COMPOUNDING—NONSTERILE ... - …
<795> PHARMACEUTICAL compounding Nonsterile PreparationsType of Posting Revision Bulletin Posting Date 22 Nov 2019 Official Date 01 Dec 2019 Expert Committee compounding Reason for Revision Compliance Postponement In accordance with the Rules and Procedures of the 2015 2020 Council of Experts, USP is postponing the official date of PHARMACEUTICAL compounding Nonsterile Preparations <795>. After publication of the revised <795> on June 1, 2019, USP received appeals on certain provisions in <795>. In accordance with USP s Bylaws, the responsible Expert Committees worked with a sense of urgency to consider the information raised in the appeals and issued decisions on the appeals. As part of the formal USP appeals process, stakeholders who submitted appeals to the compounding chapters had the opportunity to request further review by an appointed Panel, and USP has received three (3) such requests on <795>.
Nov 22, 2019 · The compounding facility’s leadership and all personnel involved in preparing, storing, packaging, and transporting CNSPs are responsible for 1) ensuring that the applicable practices and quality standards in this chapter are continually and consistently
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: